Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Watine, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watine, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 14:1450-1451, 2003
© 2003 European Society for Medical Oncology

Letters to the Editor

Laboratory variables to stratify metastatic colorectal cancer patients

J. Watine

Member of the Committee on Evidence-Based Laboratory Medicine of the International Federation of Clinical Chemistry and Laboratory Medicine, Laboratoire de biologie polyvalente, Hôpital Général, Rodez, France (E-mail: watine61@hotmail.com)

The first 10% of the full text of this article appears below.

In an article published in the February 2002 issue of Annals of Oncology by Koehne et al. [1] it was demonstrated, in a series of 3825 metastatic colorectal cancer patients who participated in 19 prospective randomised chemotherapy trials, that four baseline variables, i.e. performance status, alkaline phosphatase (ALP), white blood cell count (WBC) and number of metastatic sites, can define at . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?